Yelena Y. Janjigian, MD, discusses the long-term survival data from the KEYNOTE-811 trial of pembrolizumab plus trastuzumab ...

The UK government has set out the scope and ambition for their new Cyber Security and Resilience Bill (CSRB), which aims to ...

Mirvetuximab soravtansine improved overall survival, progression-free survival, second progression-free survival, and other outcomes.

BeiGene’s Tevimbra (tislelizumab) has been recommended by the European Medicines Agency’s human medicines committee as part of a first-line combination treatment for an aggressive form of lung cancer.

Artificial Intelligence (AI) agents have rapidly evolved from conceptual innovations to integral components within the financial services sector. By 2025, these intelligent systems will not merely ...

In 2024, casualties from landmines and unexploded ordinance surged by 22% (Landmine Monitor 2024). Figures the ICRC have gathered from early 2025 indicate that the rise in victims will further ...